Differential Expression and Prognostic Implications of the CCN Family Members WISP-1, WISP-2, and WISP-3 in Human Breast Cancer

[1]  Andrew Leask,et al.  All in the CCN family: essential matricellular signaling modulators emerge from the bunker , 2006, Journal of Cell Science.

[2]  G. Watkins,et al.  Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance. , 2006, International journal of oncology.

[3]  G. Watkins,et al.  Expression of Interleukin 11 and Its Receptor and Their Prognostic Value in Human Breast Cancer , 2006, Annals of Surgical Oncology.

[4]  T. Khor,et al.  A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma , 2006, International Journal of Colorectal Disease.

[5]  S. Merajver,et al.  Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells , 2005, Breast Cancer Research.

[6]  G. Watkins,et al.  Expression of the Transcription Factors Snail, Slug, and Twist and Their Clinical Significance in Human Breast Cancer , 2005, Annals of Surgical Oncology.

[7]  G. Watkins,et al.  Assessing microvessels and angiogenesis in human breast cancer, using VE‐cadherin , 2005, Histopathology.

[8]  Sushanta K Banerjee,et al.  Epidermal Growth Factor Induces WISP-2/CCN5 Expression in Estrogen Receptor-α-Positive Breast Tumor Cells through Multiple Molecular Cross-talks , 2005, Molecular Cancer Research.

[9]  P. Lichter,et al.  Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. , 2005, Cancer research.

[10]  G. Mann.  Less Is (Usually) More: When Is Amputation Appropriate for Treatment of Extremity Soft Tissue Sarcoma? , 2005, Annals of Surgical Oncology.

[11]  G. Watkins,et al.  Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. , 2004, Endocrine-related cancer.

[12]  G. Watkins,et al.  The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. , 2004, International journal of molecular medicine.

[13]  Troy Stevens,et al.  Open Access Activated Leukocyte Cell Adhesion Molecule in Breast Cancer: Prognostic Indicator , 2022 .

[14]  S. Merajver,et al.  WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. , 2004, Neoplasia.

[15]  J. Castellot,et al.  The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells. , 2004, Molecular human reproduction.

[16]  R. Mansel,et al.  Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer , 2004, Clinical & Experimental Metastasis.

[17]  G. Watkins,et al.  Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  R. Mansel,et al.  Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomes , 2003 .

[19]  N. Planque,et al.  A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis , 2003, Cancer Cell International.

[20]  D. Brigstock.  The CCN family: a new stimulus package. , 2003, The Journal of endocrinology.

[21]  R. Mansel,et al.  Biphasic effects of 17‐β‐estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells , 2003, Journal of cellular physiology.

[22]  L. Lau,et al.  Report on the second international workshop on the CCN family of genes , 2003, Molecular pathology : MP.

[23]  A. Levine,et al.  Overexpression of WISP-1 Down-regulated Motility and Invasion of Lung Cancer Cells through Inhibition of Rac Activation* , 2003, The Journal of Biological Chemistry.

[24]  M. Mayo,et al.  WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. , 2003, Neoplasia.

[25]  R. Elashoff,et al.  Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. , 2001, Cancer research.

[26]  R. Lothe,et al.  WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. , 2001, Gastroenterology.

[27]  R. Mansel,et al.  A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  S. Banerjee,et al.  WISP-2: a serum-inducible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells. , 2001, Biochemical and biophysical research communications.

[29]  W. Jiang,et al.  Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells. , 2000, The Journal of urology.

[30]  S. Merajver,et al.  A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  D. Botstein,et al.  WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. V. Kolesnikova,et al.  CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Walsh,et al.  Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas. , 1997, British Journal of Cancer.

[34]  I. Nazarenko,et al.  A closed tube format for amplification and detection of DNA based on energy transfer. , 1997, Nucleic acids research.

[35]  Y. Yang,et al.  Interleukin-11 and its receptor. , 1992, BioFactors.